International Flavors & Fragrances, Inc.
(NYSE : IFF)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Consumer Non Durables » Food Specialty Or Candy
symbolcompany%chnglast%shortavg$volume
HSYThe Hershey Co. 1.48%236.001.1%$251.13m
IFFInternational Flavors & Fragrances, Inc. 0.96%105.960.9%$176.41m
KKellogg Co. 1.01%73.812.5%$164.64m
DARDarling Ingredients, Inc. 2.18%63.781.5%$155.23m
LWLamb Weston Holdings, Inc. 0.19%86.451.4%$151.90m
SJMThe J. M. Smucker Co. 1.65%156.083.4%$135.07m
CAGConagra Brands, Inc. 1.76%38.221.4%$129.59m
MKCMcCormick & Co., Inc. 0.74%85.001.8%$113.97m
POSTPost Holdings, Inc. -0.58%92.8110.6%$48.37m
BROSDutch Bros, Inc. -1.11%32.230.0%$48.13m
ASHAshland, Inc. 0.27%112.413.6%$45.59m
FLOFlowers Foods, Inc. 0.99%29.134.1%$45.51m
CALMCal-Maine Foods, Inc. 1.13%59.7420.4%$41.37m
LANCLancaster Colony Corp. 1.27%205.550.9%$38.70m
FRPTFreshpet, Inc. 2.32%60.058.6%$29.45m

Company Profile

International Flavors & Fragrances, Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish segment consists of legacy Taste segment combined with N&B's Food & Beverage division and the food protection business of N&B's Health & Biosciences division. The Health & Biosciences business consists of a biotechnology-driven portfolio of enzymes, food cultures, probiotics and specialty ingredients for food, home and personal care, and health and wellness applications. The Scent business creates fragrance compounds, fragrance ingredients and cosmetic ingredients that are integral elements in the world’s finest perfumes and best-known household and personal care products. The Pharma Solutions business produces a vast portfolio including cellulosics and seaweed-based pharma excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling. The company was founded in 1833 and is headquartered in New York, NY.